Norfloxacin
PubChem CID: 4539
Connections displayed (default: 10).
Loading graph...
| Compound Synonyms | norfloxacin, 70458-96-7, Noroxin, Norfloxacine, Chibroxin, Baccidal, Sebercim, Norfloxacino, MK-366, Norfloxacinum, Barazan, Fulgram, AM-715, NFLX, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, Lexinor, Zoroxin, AM 715, MFCD00079532, Norfloxacine [INN-French], Norfloxacinum [INN-Latin], Norfloxacino [INN-Spanish], 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, 3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, CCRIS 6302, CHEBI:100246, EINECS 274-614-4, UNII-N0F8P22L1P, 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure, NSC-757250, BRN 0567897, MK-0366, N0F8P22L1P, DTXSID7037680, 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid, HSDB 8029, CHEMBL9, 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid, MLS000069650, DTXCID5017680, 3-Quinolinecarboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, NSC 757250, Norfloxacin [USAN:USP:INN:BAN:JAN], NCGC00016916-01, NCGC00016916-09, SMR000058200, Norfloxacin 100 microg/mL in Acetonitrile, CAS-70458-96-7, 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid, Norfloxacine (INN-French), Norfloxacinum (INN-Latin), Norfloxacino (INN-Spanish), NORFLOXACIN (MART.), NORFLOXACIN [MART.], C16H18FN3O3, NORFLOXACIN (USP-RS), NORFLOXACIN [USP-RS], NORFLOXACIN (EP MONOGRAPH), NORFLOXACIN (USP IMPURITY), NORFLOXACIN [EP MONOGRAPH], NORFLOXACIN [USP IMPURITY], Norflo, MK 0366, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid, Norfloxacin (USAN:USP:INN:BAN:JAN), Noroxin (TN), 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid, SR-01000000222, norfloxacina, Chibroxine, Chibroxol, Gonorcin, Nolicin, Noracin, Noraxin, Norocin, Noroxine, Norxacin, Uroxacin, Utinor, Noflo, Norfloxacine,(S), Prestwick_633, Norfloxacin protomer I, Norfloxacin (Norxacin), Norfloxacin (Standard), Norfloxacin protomer II, Spectrum_001017, NORFLOXACIN [MI], Opera_ID_1423, Prestwick0_000221, Prestwick1_000221, Prestwick2_000221, Prestwick3_000221, Spectrum2_001017, Spectrum3_000524, Spectrum4_000453, Spectrum5_001154, NORFLOXACIN [INN], NORFLOXACIN [JAN], PEFLOXACINE_met009, NORFLOXACIN [USAN], Epitope ID:119068, NORFLOXACIN [VANDF], SCHEMBL3473, Oprea1_375152, BSPBio_000261, BSPBio_002107, KBioGR_000866, KBioSS_001497, NORFLOXACIN [WHO-DD], MLS006011446, BIDD:GT0725, DivK1c_000084, SPECTRUM1500440, SPBio_001173, SPBio_002182, BPBio1_000289, Norfloxacin (JP18/USP/INN), BCBcMAP01_000218, GTPL12408, HMS500E06, HY-B0132R, KBio1_000084, KBio2_001497, KBio2_004065, KBio2_006633, KBio3_001607, J01MA06, NORFLOXACIN [ORANGE BOOK], S01AE02, NINDS_000084, Norfloxacin for system suitability, GLXC-20579, HMS1568N03, HMS1920B16, HMS2090F03, HMS2091J16, HMS2095N03, HMS2235G03, HMS3712N03, Norfloxacin for peak identification, Pharmakon1600-01500440, ALBB-015911, BCP27734, HY-B0132, RKL10074, Tox21_110682, Tox21_113441, 1-ethyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid, BBL005569, BDBM50045000, CCG-40235, NSC757250, s1509, STK177250, AKOS000417391, Tox21_110682_1, AC-6855, AN26450, BCP9000993, CS-1906, DB01059, KS-5007, 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic Acid, IDI1_000084, SMP1_000216, NCGC00016916-02, NCGC00016916-03, NCGC00016916-04, NCGC00016916-05, NCGC00016916-06, NCGC00016916-07, NCGC00016916-08, NCGC00016916-11, NCGC00016916-12, NCGC00021725-03, NCGC00021725-04, SY051390, SBI-0051464.P002, N0817, NS00000224, EN300-06467, C06687, D00210, AB00052059-18, AB00052059-19, AB00052059_20, AB00052059_21, Norfloxacin, analytical standard, >=98% (TLC), Norfloxacin, VETRANAL(TM), analytical standard, Q417897, SR-01000000222-2, SR-01000000222-3, BRD-K11196887-001-05-5, BRD-K11196887-001-15-4, BRD-K11196887-001-20-4, BRD-K11196887-001-21-2, BRD-K11196887-001-22-0, Z56926638, Norfloxacin, British Pharmacopoeia (BP) Reference Standard, Norfloxacin, European Pharmacopoeia (EP) Reference Standard, 1-Ethyl-3-carboxy-6-fluoro-7-(piperazinyl-1)-quinolin-4(1H)-one, Norfloxacin, United States Pharmacopeia (USP) Reference Standard, 1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaure, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino-3-quinolinecarboxylic acid, Norfloxacin, Pharmaceutical Secondary Standard, Certified Reference Material, (NFLX)1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-6-fluoro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid, 1-ethyl-4-oxo-6-fluoro-7-(piperazinyl)-1,4-dihydro-quinoline-3-carboxylic acid, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylicAcid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic acid, 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid #, 1-ethyl-6-fluoro-7-(1-piperazinyl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, 1-ethyl-6-fluoro-7-(1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 7-(1-Piperazinyl)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, Norfloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard, Norfloxacin for system suitability, European Pharmacopoeia (EP) Reference Standard, (norfloxacin)1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, Baccidal, Barazan, 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4,4a,8a-tetrahydro-quinoline-3-carboxylic acid (norfloxacin), 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid (Norfloxacin), 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid(1-norfloxacin), 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid(Norfloxacin), 274-614-4 |
|---|---|
| Topological Polar Surface Area | 72.9 |
| Hydrogen Bond Donor Count | 2.0 |
| Heavy Atom Count | 23.0 |
| Isotope Atom Count | 0.0 |
| Molecular Complexity | 519.0 |
| Database Name | cmaup_ingredients;pubchem |
| Defined Atom Stereocenter Count | 0.0 |
| Iupac Name | 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
| Prediction Hob | 1.0 |
| Target Id | NPT1463 |
| Xlogp | -1.0 |
| Molecular Formula | C16H18FN3O3 |
| Prediction Swissadme | 1.0 |
| Inchi Key | OGJPXUAPXNRGGI-UHFFFAOYSA-N |
| Fcsp3 | 0.375 |
| Logs | -3.753 |
| Rotatable Bond Count | 3.0 |
| Logd | 0.266 |
| Compound Name | Norfloxacin |
| Prediction Hob Swissadme | 1.0 |
| Exact Mass | 319.133 |
| Formal Charge | 0.0 |
| Monoisotopic Mass | 319.133 |
| Hydrogen Bond Acceptor Count | 7.0 |
| Molecular Weight | 319.33 |
| Covalent Unit Count | 1.0 |
| Total Atom Stereocenter Count | 0.0 |
| Total Bond Stereocenter Count | 0.0 |
| Esol | -2.2460223304347826 |
| Inchi | InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23) |
| Smiles | CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O |
| Nring | 3.0 |
| Defined Bond Stereocenter Count | 0.0 |
- 1. Outgoing r'ship
FOUND_INto/from Hypericum Sampsonii (Plant) Rel Props:Source_db:cmaup_ingredients